Imidazoline binding sites (IBS) profile modulation: key role of the bridge in determining I1-IBS or I2-IBS selectivity within a series of 2-phenoxymethylimidazoline analogues

J Med Chem. 2003 May 22;46(11):2169-76. doi: 10.1021/jm021113r.

Abstract

The alpha- and beta-methyl derivatives of 2-phenylethylimidazoline (compounds 7 and 8) and the corresponding enantiomers were prepared and tested with the purpose of studying the role played by the ethylene bridge in modulating I(1)- and I(2)-IBS selectivity. The alpha-methylation appeared to be extremely critical regarding the affinity and selectivity for the I1-IBS subtypes (I1/I2 = 186 for imidazoline 7) and the stereospecificity of interaction (eudismic ratio (S)-(-)-7/(R)-(+)-7 = 5888). Instead, even if in a more limited fashion, the -methylation tended toward I2-IBS selectivity (I2/I1 = 50 for imidazoline 8). The unsubstituted compound 4 (I2/I1 = 1479) proved to be considerably more potent and selective with respect to I2-IBS subtypes.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Binding Sites
  • Blood Pressure / drug effects
  • Heart Rate / drug effects
  • Imidazoles / chemical synthesis*
  • Imidazoles / chemistry
  • Imidazoles / pharmacology
  • Imidazoline Receptors
  • Kidney / metabolism
  • Male
  • PC12 Cells
  • Rabbits
  • Radioligand Assay
  • Rats
  • Receptors, Drug / metabolism*
  • Stereoisomerism
  • Structure-Activity Relationship

Substances

  • 2-(1-methyl-2-phenylethyl)-4,5-dihydro-1H-imidazole
  • Imidazoles
  • Imidazoline Receptors
  • Receptors, Drug
  • imidazoline I1 receptors